The Role of ARID1A in Endometrial Cancer and the Molecular Pathways Associated With Pathogenesis and Cancer Progression

被引:28
作者
Toumpeki, Chrisavgi [1 ]
Liberis, Anastasios [2 ]
Tsirkas, Ioannis [1 ]
Tsirka, Theodora [3 ]
Kalagasidou, Sofia [4 ]
Inagamova, Lola [1 ]
Anthoulaki, Xanthoula [1 ]
Tsatsaris, Georgios [1 ]
Kontomanolis, Emmanuel N. [1 ]
机构
[1] Democritus Univ Thrace, Dept Obstet & Gynecol, Alexandroupolis, Greece
[2] Hippokrateion Hosp, Dept Obstet & Gynecol 2, Thessaloniki, Greece
[3] Univ Thrace, Dept Mol Biol & Genet, Alexandroupolis, Greece
[4] Bodosakio Gen Hosp Ptolemaida, Dept Obstet & Gynecol, Ptolemaida, Greece
来源
IN VIVO | 2019年 / 33卷 / 03期
关键词
ARID1A; endometrial cancer; molecular pathways; review; TUMOR-SUPPRESSOR; CLINICOPATHOLOGICAL SIGNIFICANCE; SOMATIC MUTATIONS; CELL CARCINOMA; EXPRESSION; COMPLEXES; GENES; ADENOCARCINOMA; LANDSCAPE; COMPONENT;
D O I
10.21873/invivo.11524
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
AT-rich interaction domain 1A gene (ARID1A) encodes for a subunit of the switch/sucrose non fermentable (SWI/SNF) complex, a chromatin remodeling complex, and it has been implicated in the pathogenesis of various cancer types. In this review, we discuss how ARID1A is linked to endometrial cancer and what molecular pathways are affected by mutation or inhibition of ARID1A. We also discuss the potential use of ARID1A not only as a prognostic biomarker, but also as a target for therapeutic interventions.
引用
收藏
页码:659 / 667
页数:9
相关论文
共 79 条
[11]  
[Anonymous], EMBO J
[12]  
[Anonymous], J BIOL CHEM
[13]  
[Anonymous], J CLIN ONCOL
[14]   Epigenetics in endometrial carcinogenesis - part 2: histone modifications, chromatin remodeling and noncoding RNAs [J].
Bartosch, Carla ;
Lopes, Jose Manuel ;
Jeronimo, Carmen .
EPIGENOMICS, 2017, 9 (06) :873-892
[15]   Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers [J].
Bitler, Benjamin G. ;
Aird, Katherine M. ;
Garipov, Azat ;
Li, Hua ;
Amatangelo, Michael ;
Kossenkov, Andrew V. ;
Schultz, David C. ;
Liu, Qin ;
Shih, Ie-Ming ;
Conejo-Garcia, Jose R. ;
Speicher, David W. ;
Zhang, Rugang .
NATURE MEDICINE, 2015, 21 (03) :231-+
[16]   Management of women with uterine papillary serous cancer: A Society of Gynecologic Oncology (SGO) review [J].
Boruta, David M., II ;
Gehrig, Paola A. ;
Fader, Amanda Nickles ;
Olawaiye, Alexander B. .
GYNECOLOGIC ONCOLOGY, 2009, 115 (01) :142-153
[17]   Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer [J].
Bosse, Tjalling ;
ter Haar, Natalja T. ;
Seeber, Laura M. ;
van Diest, Paul J. ;
Hes, Frederik J. ;
Vasen, Hans F. A. ;
Nout, Remi A. ;
Creutzberg, Carien L. ;
Morreau, Hans ;
Smit, Vincent T. H. B. M. .
MODERN PATHOLOGY, 2013, 26 (11) :1525-1535
[18]   Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas [J].
Coatham, Mackenzie ;
Li, Xiaodong ;
Karnezis, Anthony N. ;
Hoang, Lien N. ;
Tessier-Cloutier, Basile ;
Meng, Bo ;
Soslow, Robert A. ;
Gilks, C. Blake ;
Huntsman, David G. ;
Stewart, Colin J. R. ;
Postovit, Lynne M. ;
Kobel, Martin ;
Lee, Cheng-Han .
MODERN PATHOLOGY, 2016, 29 (12) :1586-1593
[19]   Mutations and deletions of ARID1A in breast tumors [J].
Cornen, S. ;
Adelaide, J. ;
Bertucci, F. ;
Finetti, P. ;
Guille, A. ;
Birnbaum, D. J. ;
Birnbaum, D. ;
Chaffanet, M. .
ONCOGENE, 2012, 31 (38) :4255-4256
[20]   Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas [J].
Dal Molin, Marco ;
Hong, Seung-Mo ;
Hebbar, Sachidanand ;
Sharma, Rajni ;
Scrimieri, Francesca ;
de Wilde, Roeland F. ;
Mayo, Skye C. ;
Goggins, Michael ;
Wolfgang, Christopher L. ;
Schulick, Richard D. ;
Lin, Ming-Tseh ;
Eshleman, James R. ;
Hruban, Ralph H. ;
Maitra, Anirban ;
Matthaei, Hanno .
HUMAN PATHOLOGY, 2012, 43 (04) :585-591